Collaboration brings together GSK disease area expertise and development capability with Flagship portfolio of 40+ bioplatform companies Initial phase to identify and accelerate promising scientific ...
Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administration Co-administration of the RSV and shingles adjuvanted vaccines was ...
GSK and the National Senior Games team up to spotlight RSV risk, prevention, and the power of proactive health conversations National TV special “Redefining Aging” to launch in September, spotlighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback